Not that this has not been demonstrated before but to my surprise the questions on thyroid tumors and GLP-1 RA keep coming especially from non-endocrinologists This was a huge study that included a total of 460,032 users of GLP-1RAs, 717,792 users of SGLT2is, 2,055,583 users of DPP-4is, and 1,119,868 users of SUs GLP-1RA exposure was not associated with an increased risk of thyroid tumors compared with SGLT2is, DPP-4is, or SUs (meta-analysis: GLP-1RA vs
TB-4: cell migration Full-length thymosin beta-4 (43 amino acids) governs how repair cells move into tissue and organize once they arrive (G-actin sequestration). It biases healing toward functional tissue over rope-like scarring (Ac-SDKP anti-fibrotic signaling) and helps inflammation resolve cleanly. KLOW uses the full-length parent, not the shorter TB-500 fragment
SARS-CoV-2 infection: hijack of host cellular metabolic machinery The SARSCoV2 obviously lacks metabolic enzymes, a critical requisite for viral genomic replication, protein synthesis, and lipogenesis
The current first-line treatment options are chelators (substances that bind copper, and allow it to be excreted from the body), are D-penicillamine and trientine salts
02Protein, Fiber, and Water in the Same View GLP-1 users often need to keep nutrition basics visible when appetite changes
